Mariner’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-8,122
Closed -$1.03M 3610
2025
Q3
$1.03M Buy
8,122
+3,022
+59% +$360K ﹤0.01% 1880
2025
Q2
$625K Buy
5,100
+445
+10% +$50.8K ﹤0.01% 2161
2025
Q1
$471K Buy
4,655
+404
+10% +$39.4K ﹤0.01% 2249
2024
Q4
$393K Buy
4,251
+838
+25% +$82.3K ﹤0.01% 2380
2024
Q3
$330K Buy
3,413
+530
+18% +$47.6K ﹤0.01% 2490
2024
Q2
$247K Buy
2,883
+24
+0.8% +$2.01K ﹤0.01% 2605
2024
Q1
$236K Buy
+2,859
New +$209K ﹤0.01% 2632
2023
Q4
Sell
-3,636
Closed -$244K 3081
2023
Q3
$244K Buy
+3,636
New +$250K ﹤0.01% 2338

Other funds holding EHC

Mariner's EHC Position: Q4 2025 in Review

Mariner sold out of Encompass Health (EHC) in Q4 2025, closing a stake of 8,122 shares — an estimated $1.03M sold.

Mariner first reported a position in EHC in Q3 2023 and held it in 8 quarters. The position peaked at $1.03M in Q3 2025. 594 funds tracked by Wall St. Rank hold EHC as of Q4 2025.

  • Mariner reported no remaining Encompass Health position as of Q4 2025 after selling out during the quarter.
  • Mariner sold 8,122 Encompass Health shares in Q4 2025, an estimated $1.03M.
  • Mariner first reported a position in Encompass Health in Q3 2023 and held it in 8 quarters.
  • Mariner's Encompass Health position peaked at $1.03M in Q3 2025.
  • 594 funds tracked by Wall St. Rank held Encompass Health as of Q4 2025.

Based on Mariner's 13F filing for Q4 2025, filed 13 Feb 2026.